See leaflet
See Risk Management Plan
Dimere®
fulvestrant
Indications
- Advanced or metastatic breast cancer.
Presentations
- 250 mg x 2 vial + Administration kit: 2 syringes and 4 needles.
- 250 mg x 2 vial + Administration kit: 2 syringes and 4 needles.
